Sanofi has filed its Form 20-F with the U.S. Securities and Exchange Commission and its Document d’Enregistrement Universel containing its Annual Financial Report with the French market regulator Autorite des marches financiers. The filings cover the company’s 2025 fiscal year.
Both documents are accessible through the Sanofi investor relations website, the SEC website, and the AMF website. Hard copies containing complete audited financial statements are available upon request. Sanofi is listed on EURONEXT under the ticker SAN and on NASDAQ under the ticker SNY.